Topic: Pfizer Inc.

Pfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.. Pfizer said patients who were treated with Sutent were not surviving as long as patients who were treated with another drug, Bayer ...
Pfizer says Sutent was not working better than Bayer's Nexavar as a treatment for liver cancerPfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer.Pfizer said patients who were treated with Sutent ...